Henrik Nielsen

Prof. Henrik Nielsen


Research Focus & Metrics

Academic Career Length

37Years (1990-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2016 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
NKNicolai Krogh
Nicolai Krogh
MJMartin D. Jansson
Martin D. Jansson
SHSophia J. Häfner
Sophia J. Häfner
DTDisa Tehler
Disa Tehler
UBUlf Birkedal
Ulf Birkedal
HNHenrik Nielsen
Henrik Nielsen
Ribose methylation is one of the two most abundant modifications in human ribosomal RNA and is believed to be important for ribosome biogenesis, mRNA selectivity and translational fidelity. We have applied RiboMeth-seq to rRNA from HeLa cells for ribosome-wide, quantitative mapping of 2′-O-Me sites and obtained a comprehensive set of 106 sites, including two novel sites, and with plausible box C/D guide RNAs assigned to all but three sites. We find approximately two-thirds of the sites to be fully methylated and the remainder to be fractionally modified in support of ribosome heterogeneity at the level of RNA modifications. A comparison to HCT116 cells reveals similar 2′-O-Me profiles with distinct differences at several sites. This study constitutes the first comprehensive mapping of 2′-O-Me sites in human rRNA using a high throughput sequencing approach. It establishes the existence of a core of constitutively methylated positions and a subset of variable, potentially regulatory positions, and paves the way for experimental analyses of the role of variations in rRNA methylation under different physiological or pathological settings.

21 November 2014 in Angewandte Chemie International Edition
Verified
Journal Article
Closed access
PDF file
UBUlf Birkedal
Ulf Birkedal
MCMikkel Christensen‐Dalsgaard
Mikkel Christensen‐Dalsgaard
NKNicolai Krogh
Nicolai Krogh
RSRadhakrishnan Sabarinathan
Radhakrishnan Sabarinathan
JGJan Gorodkin
Jan Gorodkin
HNHenrik Nielsen
Henrik Nielsen

10 November 2021 in Nature Structural & Molecular Biology
Verified
Journal Article
Closed access
PDF file
MJMartin D. Jansson
Martin D. Jansson
SHSophia J. Häfner
Sophia J. Häfner
KAKübra Altinel
Kübra Altinel
DTDisa Tehler
Disa Tehler
NKNicolai Krogh
Nicolai Krogh
ALAnders H Lund
Anders H Lund

1 September 2009 in RNA Biology
Verified
Journal Article
Open access
HNHenrik Nielsen
Henrik Nielsen
SJSteinar D. Johansen
Steinar D. Johansen
Group I introns are genetic elements interrupting functional genes. They are removed from precursors at the RNA level and most catalyze their own splicing. The catalytic part of these constitutes o...

29 September 2019 in RNA Biology
Verified
Journal Article
Closed access
JHJade Hebras
Jade Hebras
NKNicolai Krogh
Nicolai Krogh
VMVirginie Marty
Virginie Marty
HNHenrik Nielsen
Henrik Nielsen
JCJérôme Cavaillé
Jérôme Cavaillé
A sequencing-based profiling method (RiboMeth-seq) for ribose methylations was used to study methylation patterns in mouse adult tissues and during development. In contrast to previous reports based on studies of human cancer cell lines, almost all methylation sites were close to fully methylated in adult tissues. A subset of sites was differentially modified in developing tissues compared to their adult counterparts and showed clear developmental dynamics. This provides the first evidence for ribosome heterogeneity at the level of rRNA modifications during mouse development. In a prominent example, the expression levels of SNORD78 during development appeared to be regulated by alternative splicing of the Gas5 host-gene and to correlate with the methylation level of its target site at LSU-G4593. The results are discussed in the context of the specialized ribosome hypothesis.

21 December 2020 in NAR Cancer
Verified
Journal Article
Open access
PDF file
NKNicolai Krogh
Nicolai Krogh
FAFazila Asmar
Fazila Asmar
CCChristophe Côme
Christophe Côme
HMHelga Fibiger Munch-Petersen
Helga Fibiger Munch-Petersen
KGKirsten Grønbæk
Kirsten Grønbæk
HNHenrik Nielsen
Henrik Nielsen
Cancer cells are addicted to ribosome biogenesis and high levels of translation. Thus, differential inhibition of cancer cells can be achieved by targeting aspects of ribosome biogenesis or ribosome function. Using RiboMeth-seq for profiling of the ∼112 2′-O-Me sites in human ribosomal RNA, we demonstrated pronounced hypomethylation at several sites in patient-derived diffuse large B-cell lymphoma (DLBCL) cell lines with a more severe perturbation in ABC-DLBCL compared to GBC-DLBCL. We extended our analysis to tumor samples from patients and demonstrated significant changes to the ribosomal modification pattern that appeared to consist of cell growth-related as well as tumor-specific changes. Sites of hypomethylation in patient samples are discussed as potential drug targets, using as an example a site in the small subunit (SSU-C1440) located in a ribosomal substructure that can be linked to DLBCL pathogenesis.